In this issue:
Fracture prevention after zoledronic acid in osteopenia
5 years after OAGB vs. RYGB
Classes and predictors of CHH reversal
Testosterone for hypogonadism:progression to diabetes and depressive syndromes
Autoimmune disorders associated with surgical remission of Cushing disease
Plasma dexamethasone concentrations after 1mg DST in obesity
Real-world experience with 11C-methionine PET for managing acromegaly
Moderate salt restriction in primary aldosteronism improves bone metabolism
Drug treatment in Cushing's disease not cured by pituitary surgery
Please login below to download this issue (PDF)